Genetic Variants in <i>HSD17B3</i>, <i>SMAD3</i>, and <i>IPO11</i> Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes
Clinical pharmacology and therapeutics/Clinical pharmacology & therapeutics